It Is Time to Harmonize the Design and Conduct of Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer

Eur Urol. 2016 Aug;70(2):263-4. doi: 10.1016/j.eururo.2015.11.025. Epub 2015 Dec 9.

Authors

Srikala S Sridhar¹, Christopher J Sweeney²

Affiliations

¹ Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
² Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: christopher_sweeney@dfci.harvard.edu.

PMID: 26683759
DOI: 10.1016/j.eururo.2015.11.025

No abstract available

Publication types

Editorial
Comment

MeSH terms

Androgen Antagonists*
Humans
Male
Prostatic Neoplasms
Taxoids*

Substances

Androgen Antagonists
Taxoids